3.005
price down icon3.06%   -0.095
after-market After Hours: 3.05 0.045 +1.50%
loading
Annexon Inc stock is traded at $3.005, with a volume of 1.14M. It is down -3.06% in the last 24 hours and up +24.17% over the past month. Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
See More
Previous Close:
$3.10
Open:
$3.12
24h Volume:
1.14M
Relative Volume:
0.70
Market Cap:
$330.21M
Revenue:
-
Net Income/Loss:
$-134.24M
P/E Ratio:
-1.6977
EPS:
-1.77
Net Cash Flow:
$-121.34M
1W Performance:
-5.50%
1M Performance:
+24.17%
6M Performance:
+101.68%
1Y Performance:
-59.28%
1-Day Range:
Value
$2.925
$3.1795
1-Week Range:
Value
$2.925
$3.30
52-Week Range:
Value
$1.285
$7.85

Annexon Inc Stock (ANNX) Company Profile

Name
Name
Annexon Inc
Name
Phone
(650)-822-5500
Name
Address
1400 SIERRA POINT PARKWAY, BRISBANE
Name
Employee
103
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
ANNX's Discussions on Twitter

Compare ANNX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ANNX
Annexon Inc
3.005 340.65M 0 -134.24M -121.34M -1.77
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Annexon Inc Stock (ANNX) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-01-24 Upgrade JP Morgan Neutral → Overweight
Dec-21-23 Upgrade BofA Securities Neutral → Buy
Oct-30-23 Initiated Wells Fargo Overweight
May-26-23 Downgrade BofA Securities Buy → Neutral
May-25-23 Downgrade JP Morgan Overweight → Neutral
Sep-16-22 Initiated Jefferies Buy
Sep-09-22 Initiated BTIG Research Buy
Nov-30-21 Initiated H.C. Wainwright Buy
Sep-23-21 Initiated Cantor Fitzgerald Overweight
Jan-26-21 Initiated Needham Buy
Aug-18-20 Initiated BofA Securities Buy
Aug-18-20 Initiated Cowen Outperform
Aug-18-20 Initiated JP Morgan Overweight
View All

Annexon Inc Stock (ANNX) Latest News

pulisher
11:05 AM

Is Annexon Inc. stock a defensive play in 2025Inflation Watch & Free Expert Verified Stock Movement Alerts - newser.com

11:05 AM
pulisher
11:02 AM

Is it time to cut losses on Annexon Inc.Trade Analysis Report & Expert Approved Momentum Ideas - newser.com

11:02 AM
pulisher
08:29 AM

Is Annexon Inc. stock poised for growthEarnings Growth Summary & Weekly Market Pulse Updates - newser.com

08:29 AM
pulisher
08:02 AM

How geopolitical tensions affect Annexon Inc. stockPortfolio Gains Summary & Stepwise Entry/Exit Trade Alerts - newser.com

08:02 AM
pulisher
04:37 AM

Will Annexon Inc. stock deliver better than expected guidanceJuly 2025 Closing Moves & High Accuracy Swing Entry Alerts - newser.com

04:37 AM
pulisher
01:32 AM

Key metrics from Annexon Inc.’s quarterly dataPortfolio Risk Report & Reliable Entry Point Alerts - newser.com

01:32 AM
pulisher
Oct 12, 2025

Analyzing drawdowns of Annexon Inc. with statistical toolsJuly 2025 Recap & Reliable Entry Point Trade Alerts - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Should you wait for a breakout in Annexon Inc.Stock Surge & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

What data driven models say about Annexon Inc.’s futureWatch List & Verified Momentum Stock Alerts - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Full technical analysis of Annexon Inc. stockJuly 2025 Sentiment & Free Reliable Trade Execution Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Annexon Inc.’s volatility index tracking explainedDollar Strength & Safe Capital Growth Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will Annexon Inc. outperform the marketIPO Watch & Weekly Market Pulse Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Why Annexon Inc. stock is seen as undervaluedJuly 2025 Closing Moves & Scalable Portfolio Growth Ideas - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Annexon's (ANNX) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat

Oct 08, 2025
pulisher
Oct 06, 2025

Does Annexon Inc. show high probability of reboundOil Prices & Short-Term High Return Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Annexon Inc. stock outperform Nasdaq indexEarnings Risk Summary & Technical Buy Zone Confirmation - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Annexon Inc. stock maintain momentum in 2025Rate Cut & Reliable Breakout Forecasts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Is Annexon Inc. stock entering bullish territory2025 Trade Ideas & Fast Exit and Entry Trade Guides - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Annexon Inc. stock bottoming out2025 Dividend Review & Weekly Market Pulse Updates - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Statistical indicators supporting Annexon Inc.’s strengthPortfolio Value Summary & Consistent Profit Trading Strategies - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

J. Safra Sarasin Holding AG Purchases 126,903 Shares of Annexon, Inc. $ANNX - MarketBeat

Oct 05, 2025
pulisher
Oct 03, 2025

Annexon, Inc. (NASDAQ:ANNX) Given Consensus Rating of "Hold" by Analysts - MarketBeat

Oct 03, 2025
pulisher
Oct 03, 2025

Price action breakdown for Annexon Inc.2025 Price Momentum & Reliable Volume Spike Trade Alerts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Annexon, Inc. $ANNX Holdings Lifted by Park Avenue Securities LLC - Defense World

Oct 02, 2025
pulisher
Oct 02, 2025

Annexon (NASDAQ:ANNX) Director Acquires $12,550.75 in Stock - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

Insider Buying: William Carson Acquires Shares of Annexon Inc (A - GuruFocus

Oct 02, 2025
pulisher
Sep 30, 2025

Nuveen Expands Portfolio With Annexon, Inc. (ANNX) Acquisition - Insider Monkey

Sep 30, 2025

Annexon Inc Stock (ANNX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Annexon Inc Stock (ANNX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Carson William H.
Director
Sep 02 '25
Buy
2.09
4,115
8,600
37,945
Carson William H.
Director
Jul 30 '25
Buy
2.43
4,115
9,999
33,830
Yednock Ted
EVP & CHIEF INNOVATION OFFICER
Jul 14 '25
Sale
2.58
1,116
2,879
105,084
Lew Jennifer
EVP & CHIEF FINANCIAL OFFICER
Jul 14 '25
Sale
2.58
1,117
2,882
121,616
Overdorf Michael
EVP & CHIEF BUSINESS OFFICER
Jul 14 '25
Sale
2.61
853
2,226
130,689
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):